JAMA Article Says TAXUS® Stents Half As Likely To Require Reintervention In Complex Lesions
(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V clinical trial that found the TAXUS